Lululemon’s Stock Plummets 18.4%—What’s Behind the Crash
As an investor and a fan of $Lululemon Athletica(LULU)$ , I was stunned to see their stock crash 18.4% in a single day, wiping out much of its recent gains. Having tracked this company, I know its stock once soared past $500, a massive leap from its low of $2.17—a 200x increase! Now trading at just $168, a level last seen in the 2020 bear market, I’m left wondering: what fueled Lululemon’s incredible rise, and why did it plummet this week? Can its business model pull through, and what makes premium athletic brands like this so special? Here’s my perspective: Lululemon’s drop stems from a mix of disappointing earnings, intense competition, and macroeconomic pressures. Their Q2 2025 earnings, released after market close on Sep
BioNTech Stock Soars 10% on Breakthrough Cancer Drug Results!
Big news in the biotech world! BioNTech’s stock surged 10% this past Friday after their cancer drug BNT323/DB-1303 delivered stellar results in a Phase III trial for HER2-positive unresectable or metastatic breast cancer. Conducted in China by partner Duality Biotherapeutics, the trial hit its primary endpoint of progression-free survival, outperforming Roche’s trastuzumab emtansine (T-DM1). $BioNTech SE(BNTX)$ Duality Biotherapeutics$DUALITYBIO-B(09606)$ , holding commercial rights in China, is now gearing up to submit a Biologics License Application to China’s NMPA. Meanwhile, BioNTech, with global rights outside China, is running a global
FIGURE’s IPO positioning is interesting. The underwriter line-up (Goldman Sachs, Citigroup, etc.) suggests institutional confidence, while the $17–$19 pricing range appears designed to balance demand with a manageable entry point. From a financial perspective, the topline growth is notable—revenue of $142.2M in 2024, up from $98.1M in 2023, represents a ~45% YoY increase. That scale of acceleration, especially in fintech where margins can improve with scale, does raise the “breakout” question. However, a few considerations remain critical before declaring FIGURE the next big success story: Profitability: Revenue growth is strong, but investors will want clarity on operating income, net margins, and customer acquisition costs. Valuation multiple: At a $4.1B valuation, the implied price-to-s
Elon Musk’s new compensation package is one of the most aggressive incentive structures in corporate history—$87.8 billion today, with the potential to reach nearly $1 trillion if all performance milestones are achieved. The design clearly ties his rewards to Tesla’s market value, operational execution, and long-term leadership planning. From a financial and strategic standpoint, here are the implications for a potential “supercycle”: 1. Alignment of Interests: By conditioning the largest tranches on Tesla’s sustained performance and Musk’s participation in succession planning, the board is effectively binding Musk’s legacy (and wealth) to Tesla’s growth trajectory. This ensures laser-focus on execution in AI, EV expansion, and energy storage. 2. Investor Confidence & Narrative: Market
🚀 Tesla's $1 Trillion Package: Catalyst or Ceiling?
History shows Elon Musk delivers when the stakes are sky-high. This latest $87.8B compensation package—potentially swelling to $1T—aligns perfectly with Tesla's growth story. The market views it as both a motivational lever and a confidence signal that Musk is locked in for the long game. Why it matters now: Momentum & psychology → Musk's track record means institutions will price in higher probabilities of execution. Macro tailwinds → Potential Fed cuts + EV incentives could give Tesla a demand and liquidity boost. Technical watch → $TSLA has resistance around $260–265. A clean breakout with volume could set up a run toward $300. Failure here risks a pullback to the $230 support zone. The risk? Execution timelines. Musk often stretches targets, and short-term volatility around deliver
When Tiger Brokerage first launched the Trade Feed program, I was stoked to be included. The idea was simple: share your trades, earn Tiger Coins, and maybe gain some followers along the way. At the start, I was excited about the prospect of building an audience while posting my trades. It felt like a recognition of my trading journey and an opportunity to be part of a wider community. But over time, I realized the real value wasn’t in gaining followers — it was in the process of sharing and reflecting on my trades. The Trade Feed gradually became my personal trading journal, a place where I analyze past trades, track how stocks move over the weeks, and prepare for future setups. Revisiting my trades has been an invaluable way to sharpen my discipline and refine my strategies. Another unex
SGX September Dividend Ex-Date Playbook | 🦖 #TheInvestingIguana EP1073
🟩 🦖 Stop losing money on ex-dates with smarter timing strategies! This video is packed with insights to help you avoid costly mistakes and boost your dividend investing game. Learn how to map ex-dates, fix timing issues, and make better investment decisions with Iggy from The Investing Iguana. Whether you're navigating Singapore’s SGX market, exploring CPF/SRS advantages, or managing REIT clusters, this guide sheds light on sequences, pricing mechanics, and risk management. 📈 Dive into practical tips like building a six-week ex-date calendar, leveraging post-ex-date opportunities, and optimizing reinvestment flows. From Capitaland India Trust to Riverstone, Iggy shares actionable advice to turn timing into your investing superpower. Plus, uncover second-order effects, currency impacts like
I won’t chase AVGO’s rally. The best chips available is still from Nvidia. AVGO can only be considered second option if one cannot get hold of Nvidia’s chips due to the high demand or the high price point. In the longer term. AVGO’s chips demand will still be high as long as NVDA cannot keep up with all of market’s demand. However, if NVDA can keep up, demand for AVGO should drop. With the recent rally, I find that the safety margin for it has reduced and I would prefer to watch for the dip to consider entry. NVDA’s dip may continue to dip further with increased competition. However, I still have faith in it’s superiority and will allow the full dip before considering entering too. Otherwise, the safer option for me would be to buy SMH and hold.
I see bitcoin as the best safe haven over 3 years because the rate and potential of growth Will far exceed gold and silver. The main driver is of course its limited supply and potentially increased demand. While gold and silver may rise, I don’t see it outpacing bitcoin. Silver is the poor man’s gold and so usually follows the trend for gold price but will always lag behind. So, silver is the least of my preference. I don’t think gold will become the new monetary anchor. Gold is just comparatively a slightly safer option to hold in times of uncertainty and also tend to offer greater returns than treasuries in such times. I see it mainly as a business decision rather than a true change of conviction. Treasuries yield in recent years have been disappointing and probably is a useless asset
Elon has been instrumental in the success of$Tesla Motors(TSLA)$ however this does not give him a right to plunder and blackmail. Corporate governance is only a sham when companies boards are controlled and vote on the whims of the CEO and MD. But my grouse is also with the banks which provide cash for this company and why are they not asking for better governance. The CEO can run into politics, he can handle multiple large companies so where will be his focus? However in the corporate world most companies corporate is like that whether it's Jeff, Zuckerberg or Jack Ma But a few companies have transitioned to professional CEO s like Google, Microsoft etc. the front runner was Ford who stepped down
The Power of Patience: Buffett’s Sister Turned $200 into $610,000 by “Lying Flat”
Sometimes the best investment strategy is simply to do nothing. Warren Buffett’s sister, Bertie, proved exactly that. In 1980, she bought Berkshire Hathaway shares at just $200 each. She didn’t chase trends, didn’t panic-sell, and didn’t try to time the market. Instead, she simply held on. Fast forward 44 years — those same shares are now worth $610,000 apiece. Her wealth multiplied by an astonishing 3,050 times. Even after giving away hundreds of millions to charity, she remains incredibly wealthy. 💪 That’s the ultimate form of “lying flat” — letting time and compounding do the heavy lifting. Her brother, Warren Buffett, has always emphasized patience, discipline, and long-term thinking. He himself pledged to donate more than 99% of his fortune to charity, with his three children acting a
🔥🚀📈 7 Small-Mid Cap Breakout Stars to Watch Now 📈🚀🔥
$Rocket Lab USA, Inc.(RKLB)$$Oscar Health, Inc.(OSCR)$$IREN Ltd(IREN)$ 🚀 $RKLB – Owning the Space Race I’m long here. Daily chart shows EMA reaccumulation with upside momentum. Mars comms + Neutron rockets = serious moat. Holding $900 MXN keeps the path clear to push higher. 💊 $OSCR – Reinventing Health Insurance Ripping through upper Keltner bands with strong volume. If it holds above $19.50, I see a clear runway toward $21. Growth + healthtech disruption in one package. 🌱 $HIMS – The Future of Wellness Beautiful reversal. EMAs flipped bullish, momentum regained. Above $49, this name enters price discovery. Wellness TAM keeps compounding, and Hims keeps
🔥💎🚀 Oscar Health: The Perfect Storm for a Breakout 🚀💎🔥
$Oscar Health, Inc.(OSCR)$ I’m convinced $OSCR is one of the most asymmetric opportunities in the market right now. The mix of high short interest, relentless accumulation signals, breakout technicals, and management reaffirming guidance has created a setup that’s too powerful to ignore. The real squeeze hasn’t even started. 📊 Short Data That Screams Convexity Short interest stands at nearly 24% with open short positions at 57.7M shares. That translates to just over 3 days to cover. Daily short volume remains elevated at 2.75M, with whales steadily participating. This is tinder waiting for a spark. Once momentum accelerates, the unwind could force a violent repricing higher. 🧩 Technical Blueprint for Expansion Price is pressing into the $20–$22 zo
🌟🌟🌟All eyes will be on Figure and Gemini IPOs - Which is a Better Buy? Let's break it down. This isn't just a numbers game. It is a clash of philosophies. Figure $Figure Technology Solutions (FT Intermediate)(FIGR)$ business model is tokenising real world assets ( RWAs) such as mortgages, treasuries and loans on its Provenance Blockchain. It is like Wall Street meets Web 3. Figure Financials (H1 2025) : Revenue is USD 191 million. Profit: USD 29 million. YoY Growth : +22% Valuation : Up to USD 4.6 billion IPO Raise : USD 526 million Backers : Goldman Sachs, Jefferies, Bank of America. Edge: Already tokenised USD 50 billion in assets. Processing times slashed from 42 days to 10 days
🌟🌟🌟Open Sesame to Opendoor $Opendoor Technologies Inc(OPEN)$. Up 280% year todate and still climbing like it has found Ali Baba's treasure chest buried under the sands of Nasdaq. With 24% of the float shorted, this was less of a recovery play and more of a genie escape. Once the squeeze began, it was Open Sesame and poof - the hedge funds vanished in a cloud of margin calls! Retail investors from Reddit saw the chart, whispered abracadabra, and now Opendoor is trading like it has got Zillow's wand and Carvana's magic cape. Rate cut hopes sprinkled fairy dust on housing stocks. Lower mortgage rates equals more transactions and Opendoor's flying carpet gets a tailwind. If you are tactical & love a good squeeze, this is your g
This is a typical meme stock where it would be hard to predict if there are sufficient diamond hands among the retail investors to force a short squeeze. Even though it has already rallied so much, hedge funds are still shorting it, and this suggests that fundamentally the big whales don’t think it is worthy of the current price and are not afraid to take on the retail investors head on. I am not optimistic that opendoor could become the next carvana. Meme stocks are beyond my risk appetite, so I would prefer to stay on the sidelines. This situation really can play out anyway and I don’t want to risk burning my fingers. @Kaixiang @Universe宇宙
Lululemon's 56% Crash to 2020 Lows: Dip Buy Dream or Tariff Nightmare?
$Lululemon Athletica(LULU)$ Lululemon's stock nosedived after slashing its full-year outlook, citing a $240 million tariff hit and sluggish U.S. sales, with Q2 earnings topping EPS estimates at $2.40 but missing revenue at $2.4 billion versus $2.41 billion expected. The company blamed tariffs and the de minimis exception removal for crimping growth, marking three straight quarters of declines and a 56% YTD loss to $265, back to 2020 levels. Competition from Alo further erodes market share, but international sales offer a glimmer. With the S&P 500 at 6,512.34, Nasdaq at 21,918.45, and Bitcoin at $123,456, the VIX at 14.12 reflects calm amid tariffs and oil at $74.50/barrel. Would you buy the dip on Lululemon? Products or stock—which wins your w
Bessent's Jobs Bombshell: Immigrant Surge Sparks Market Mayhem!
Treasury Secretary Scott Bessent's claim that most jobs created under the Biden administration went to illegal immigrants has ignited fierce debate, linking blue-collar wage growth to Trump's border crackdown and deportations. As employment data shows 3.2 million job gains for immigrants versus 1.9 million for native-born Americans since the pandemic, investors are reevaluating labor market stocks, immigration policies, and economic impacts. With the S&P 500 at 6,512.34, Nasdaq at 21,918.45, and Bitcoin at $123,456, the VIX at 14.12 reflects calm amid tariffs (30-35% on EU/Mexico/Canada) and oil at $74.50/barrel. How will this reshape the market? Is Bessent's statement a policy preview or political rhetoric? This deep dive explores the claim, economic implications, stock impacts, and s
$NVIDIA(NVDA)$ I’m fully convinced NVDA is rolling into a deeper corrective phase. The harmonic symmetry, gap magnets at $149–$145, and Keltner/Bollinger breakdowns all line up for continuation. Momentum is on the side of the bears short term, and I’m not fighting it. Instead, I’m leaning into tactical setups with both direct NVDA trades and inverse ETF vehicles like NVDQ and NVDS. 📊 Technical Breakdown I’m seeing NVDA roll right out of its wedge top into a clean descending channel. The structure points toward deeper retests, and the confluence across multiple timeframes tells me the path of least resistance is still lower. The $149 and $145 gaps remain highly magnetic as liquidity zones waiting to be tapped. 🔷 Harmonic Alignment The harmonic leg
🚨 CPI, iPhone 17, and Tesla’s $44M Call Surge – The Ultimate Playbook for 08Sep25 🚨
$Tesla Motors(TSLA)$$Apple(AAPL)$$Oracle(ORCL)$ I’m positioning for a data-driven volatility burst as CPI drops hours after the ECB, Apple unveils iPhone 17, and $TSLA prints $44M in net call buying into a $353 inflection. 📊 Macro catalysts I’m trading around Tuesday 09Sep25: Apple’s iPhone 17 event. Hardware reveals often reset supplier sentiment and index microstructure; any ASP uplift or AI edge will flow through to $AAPL weight in $QQQ. Wednesday 10Sep25: US PPI at 8:30 a.m. ET; the first inflation read of the week. Thursday 11Sep25: US CPI at 8:30 a.m. ET, Jobless Claims at 8:30 a.m. ET, plus the ECB decision and press conference earlier in the morning. Fr